Article

Poor, uninsured most likely to see poorly

Individuals who are visually impaired are more likely to be in a lower socioeconomic bracket in the United States, not to have private insurance, and to have an eye disease that is undetected.

Los Angeles-Individuals who are visually impaired are more likely to be in a lower socioeconomic bracket in the United States, not to have private insurance, and to have an eye disease that is undetected. Visually impaired persons who are of working age suffer the greatest economic impact because of their disability, said Rohit Varma, MD, MPH.

The survey also showed that the economic impact of visual impairment is greatest among individuals in the younger age groups, those who are of working age, Dr. Varma said.

Visually impaired individuals are less likely to have private insurance. They are more likely to be receiving Medicare or Medicaid benefits.

Regarding employment, the same type of pattern emerges in the national survey. These individuals are less likely to be employed.

"Almost one-third of those who are visually impaired believe that they are prevented from working as a result of their impairment," he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.